Aurobindo Upbeat On Outlook, Transfers Biologics Biz

Seeks FDA Desk Reviews For Three Units

 
• By Vibha Ravi
Business growth
Aurobindo Looks For Growth As It Carves Out Biologics Business • Source: Shutterstock

More from Business

More from Scrip